Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/1998
04/08/1998CN1178106A Cyclosphorin-containing soft capsule preparation
04/07/1998US5736578 Treatment of sleep disorders
04/07/1998US5736568 2-(aminoalkoxy) phenylalkylamines with antiinflammatory activity
04/07/1998US5736549 Hypoxanthine and guanine compounds
04/07/1998US5736519 Enhances reconstitution of cells of hematopoietic and immune systems following radiation or chemotherapy induced suppression
04/07/1998US5736507 Peptide of human cartilage glycoprotein 39, which stimulates autoreactive t-cells found in blood of rheumatoid arthritis patients
04/07/1998US5736390 BCRF1 proteins as inhibitors of interferon-γ
04/07/1998US5736381 An isolated and purified polynucleotide sequence encoding a polypeptide containing specific amino acid sequence
04/07/1998US5736362 An isolated nucleic acid comprising nucleotide sequence encoding amino acid sequence 25-276 of a rye grass pollen protein
04/07/1998US5736340 Secreted Mac-2-binding glycoprotein
04/07/1998US5736337 Inhibiting protein interactions
04/07/1998US5736149 Allergenic proteins and peptides from johnson grass pollen
04/07/1998US5736143 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
04/07/1998US5736142 Alteration of immune response using pan DR-binding peptides
04/07/1998US5736138 Antagonist
04/07/1998CA1339802C Diarylstrylquinoline diacids
04/02/1998WO1998013380A1 Snrnp sm proteins
04/02/1998WO1998013374A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
04/02/1998WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
04/02/1998WO1998013354A1 Quinazoline derivatives and pharmaceutical compositions containing them
04/02/1998WO1998013067A1 Method of preventing acute rejection following solid organ transplantation
04/02/1998WO1998013066A1 Anti-class ii mhc binding agents for use in xenotransplantation
04/02/1998WO1998013061A1 Inhibition of 26s and 20s proteasome by indanones
04/02/1998WO1998013055A1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
04/02/1998WO1998013053A1 Mistletoe (viscum) extracts
04/02/1998WO1998013052A1 Anti-allergic and anti-inflammatory product, method for producing the same, cosmetic product and hygienic product
04/02/1998WO1998013049A1 Method for preparing a product in particular for preventing and curing skin diseases, and resulting product
04/02/1998WO1998013031A2 Medicinal aerosol formulations comprising budesonide
04/02/1998DE19639375A1 Mistel-Trockenextrakte Mistletoe dried extracts
04/02/1998DE19638313A1 Composition containing immunomodulatory peptide or protein and adjuvant
04/02/1998CA2658989A1 Tripterygium wilfordii preparations and uses thereof
04/02/1998CA2266431A1 Medicinal aerosol formulations comprising budesonide
04/02/1998CA2266329A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
04/02/1998CA2266315A1 Method of preventing acute rejection following solid organ transplantation
04/02/1998CA2265950A1 Spiro-azacyclic derivatives and their use as therapeutic agents
04/02/1998CA2264544A1 Snrnp sm proteins
04/01/1998EP0832977A2 Novel sugar kinase
04/01/1998EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus
04/01/1998EP0832973A2 GTP-binding protein
04/01/1998EP0832900A1 Peptide and method of obtaining it
04/01/1998EP0832253A2 Nucleic acid respiratory syncytial virus vaccines
04/01/1998EP0832236A1 Methods for enhancement of protective immune responses
04/01/1998EP0832231A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
04/01/1998EP0832227A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
04/01/1998EP0832223A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION
04/01/1998EP0832213A1 TNF-$g(a) RIBOZYMES, TNF-$g(a) RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES
04/01/1998EP0832135A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES
04/01/1998EP0832134A1 Anti-allergy bispecific molecules
04/01/1998EP0832126A1 G-protein receptor htnad29
04/01/1998EP0832112A1 Monocyte chemotactic protein-4
04/01/1998EP0832099A1 Reversible cysteine protease inhibitors
04/01/1998EP0832093A1 Expression of lipoproteins
04/01/1998EP0832081A1 Bicyclic-aromatic compounds
04/01/1998EP0832078A1 N-hydroxyureas as antiinflammatory agents
04/01/1998EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
04/01/1998EP0832071A1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
04/01/1998EP0832063A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments
04/01/1998EP0831939A1 Structurally determined metallo-constructs and applications
04/01/1998EP0831925A1 The regulation of systemic immune responses utilizing cytokines and antigens
04/01/1998EP0831917A2 Immunotoxins specific for cd80 and cd86 expressing cells
04/01/1998EP0831906A1 Treatment of t cell mediated autoimmune disorders
04/01/1998EP0831893A1 Regulation of cytokine synthesis and release
04/01/1998EP0831875A1 Methods of inhibiting phagocytosis
04/01/1998EP0831841A1 Means for treating radiation injuries
04/01/1998EP0831826A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
04/01/1998EP0831820A1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
04/01/1998EP0831817A1 Antigen-processing cell-targeted conjugates
04/01/1998EP0831771A2 Oral delivery of gene constructs
04/01/1998EP0741707B1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
04/01/1998EP0572451B1 Novel steroid esters
04/01/1998EP0466838B1 Novel lipid a derivatives and uses therefor
04/01/1998CA2216486A1 Substituted diamino-1,3,5-triazine derivatives
03/1998
03/31/1998US5734057 HIV protease inhibitors and intermediates
03/31/1998US5734051 8-substituted xanthine derivatives and method of use thereof
03/31/1998US5733929 Pharmaceutical composition for treating or preventing allergic rhinitis
03/31/1998US5733928 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
03/31/1998US5733927 Antitumor agents and immunology
03/31/1998US5733923 Secretory pancreatic phospholipase a2
03/31/1998US5733907 Aids therapy
03/31/1998US5733881 Analgesics, immunosuppressants
03/31/1998US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
03/31/1998US5733548 Stimulating t-cell response
03/26/1998WO1998012223A1 Novel human interferon-inducible protein
03/26/1998WO1998012221A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
03/26/1998WO1998011918A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation
03/26/1998WO1998011909A1 Use of proteins as agents against autoimmune diseases
03/26/1998WO1998011907A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
03/26/1998WO1998011894A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound
03/26/1998WO1998003653A3 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor
03/26/1998WO1997048370A3 Vaccines comprising synthetic genes
03/26/1998DE19704301C1 Human endoglin gene promoter
03/26/1998DE19639103A1 DNA construct with inhibitory mutation and corrective mutation
03/26/1998CA2266684A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation
03/26/1998CA2266346A1 Use of proteins as agents against autoimmune diseases
03/26/1998CA2265571A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
03/26/1998CA2263821A1 Novel human interferon-inducible protein
03/26/1998CA2238043A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound
03/25/1998EP0830860A1 Use of PKC inhibitors for the manufacture of a medicament for the treatment of AIDS
03/25/1998EP0830455A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
03/25/1998EP0830374A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
1 ... 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 ... 1172